

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77577961 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.77577961 |
| 3 | detection of other organism (GO:0098543) | 4.65104250 |
| 4 | detection of bacterium (GO:0016045) | 4.53370495 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35899857 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.31749974 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 4.29408334 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 3.85643926 |
| 9 | detection of external biotic stimulus (GO:0098581) | 3.82559672 |
| 10 | leukocyte aggregation (GO:0070486) | 3.77452055 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.70609857 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.70258641 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 3.63460875 |
| 14 | neutrophil activation (GO:0042119) | 3.61161068 |
| 15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.60627165 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57408089 |
| 17 | regulation of mast cell degranulation (GO:0043304) | 3.51410445 |
| 18 | granulocyte activation (GO:0036230) | 3.46177294 |
| 19 | negative regulation of phagocytosis (GO:0050765) | 3.45467586 |
| 20 | response to host immune response (GO:0052572) | 3.42948184 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42948184 |
| 22 | DNA unwinding involved in DNA replication (GO:0006268) | 3.41679354 |
| 23 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.41669134 |
| 24 | myeloid cell activation involved in immune response (GO:0002275) | 3.41620479 |
| 25 | detection of biotic stimulus (GO:0009595) | 3.38321334 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.37613645 |
| 27 | positive thymic T cell selection (GO:0045059) | 3.37351894 |
| 28 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.37219399 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 3.37068256 |
| 30 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.35732307 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 3.33304901 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32569082 |
| 33 | response to interleukin-15 (GO:0070672) | 3.32523277 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.30832021 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.30832021 |
| 36 | response to type I interferon (GO:0034340) | 3.28295410 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.27966848 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27895431 |
| 39 | DNA strand elongation (GO:0022616) | 3.25066239 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22540253 |
| 41 | germinal center formation (GO:0002467) | 3.21955438 |
| 42 | protein localization to kinetochore (GO:0034501) | 3.21898830 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.20866280 |
| 44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.20729955 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.19409493 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.18944374 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18718389 |
| 48 | positive regulation of mast cell activation (GO:0033005) | 3.17974281 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.17400566 |
| 50 | negative T cell selection (GO:0043383) | 3.16483788 |
| 51 | B cell mediated immunity (GO:0019724) | 3.15426648 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14798653 |
| 53 | response to host (GO:0075136) | 3.14249216 |
| 54 | response to host defenses (GO:0052200) | 3.14249216 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14249216 |
| 56 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.13453092 |
| 57 | respiratory burst (GO:0045730) | 3.07821667 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.06786921 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05088090 |
| 60 | macrophage activation (GO:0042116) | 3.02650591 |
| 61 | regulation of tolerance induction (GO:0002643) | 3.01722985 |
| 62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01271003 |
| 63 | viral transcription (GO:0019083) | 3.00779885 |
| 64 | response to fungus (GO:0009620) | 2.99883566 |
| 65 | DNA replication initiation (GO:0006270) | 2.96560376 |
| 66 | microglial cell activation (GO:0001774) | 2.96247130 |
| 67 | regulation of mast cell activation (GO:0033003) | 2.96126877 |
| 68 | defense response to fungus (GO:0050832) | 2.95382181 |
| 69 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94994804 |
| 70 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.94689467 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 2.94511159 |
| 72 | regulation of antigen processing and presentation (GO:0002577) | 2.93916326 |
| 73 | T cell selection (GO:0045058) | 2.91656617 |
| 74 | leukocyte degranulation (GO:0043299) | 2.90911991 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90662903 |
| 76 | translational termination (GO:0006415) | 2.88796765 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87254021 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87186344 |
| 79 | thymic T cell selection (GO:0045061) | 2.85123541 |
| 80 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84034015 |
| 81 | response to peptidoglycan (GO:0032494) | 2.83631532 |
| 82 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.83493323 |
| 83 | negative regulation of innate immune response (GO:0045824) | 2.82799941 |
| 84 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81724222 |
| 85 | protein localization to chromosome, centromeric region (GO:0071459) | 2.81446773 |
| 86 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.80862303 |
| 87 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.80862303 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 2.80530851 |
| 89 | formation of translation preinitiation complex (GO:0001731) | 2.78964225 |
| 90 | telomere maintenance via recombination (GO:0000722) | 2.78384080 |
| 91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.78374991 |
| 92 | macrophage differentiation (GO:0030225) | 2.77153000 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.76739433 |
| 94 | myeloid dendritic cell differentiation (GO:0043011) | 2.76165641 |
| 95 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75403221 |
| 96 | pentose-phosphate shunt (GO:0006098) | 2.73873235 |
| 97 | IMP metabolic process (GO:0046040) | 2.73482349 |
| 98 | neutrophil mediated immunity (GO:0002446) | 2.73214856 |
| 99 | cellular extravasation (GO:0045123) | 2.72500748 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71356963 |
| 101 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.70278968 |
| 102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66829614 |
| 103 | IMP biosynthetic process (GO:0006188) | 2.65814602 |
| 104 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.63612601 |
| 105 | translational elongation (GO:0006414) | 2.62619867 |
| 106 | actin nucleation (GO:0045010) | 2.62117632 |
| 107 | mitotic recombination (GO:0006312) | 2.60986478 |
| 108 | negative regulation of interleukin-12 production (GO:0032695) | 2.60934829 |
| 109 | hepatocyte apoptotic process (GO:0097284) | 2.59584016 |
| 110 | response to protozoan (GO:0001562) | 2.58628044 |
| 111 | B cell receptor signaling pathway (GO:0050853) | 2.58507485 |
| 112 | neutrophil activation involved in immune response (GO:0002283) | 2.57520216 |
| 113 | maturation of SSU-rRNA (GO:0030490) | 2.56498549 |
| 114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.53839673 |
| 115 | negative regulation of cell killing (GO:0031342) | 2.53839673 |
| 116 | nucleobase biosynthetic process (GO:0046112) | 2.53497596 |
| 117 | modulation by symbiont of host defense response (GO:0052031) | 2.52761458 |
| 118 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52761458 |
| 119 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.52761458 |
| 120 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52761458 |
| 121 | modulation by symbiont of host immune response (GO:0052553) | 2.52761458 |
| 122 | positive regulation by symbiont of host defense response (GO:0052509) | 2.52761458 |
| 123 | defense response to protozoan (GO:0042832) | 2.51198382 |
| 124 | positive regulation of lamellipodium assembly (GO:0010592) | 2.50172850 |
| 125 | T cell migration (GO:0072678) | 2.48392576 |
| 126 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.47843883 |
| 127 | cellular response to zinc ion (GO:0071294) | 2.47053212 |
| 128 | mitotic nuclear envelope disassembly (GO:0007077) | 2.45271551 |
| 129 | pinocytosis (GO:0006907) | 2.45170317 |
| 130 | leukocyte cell-cell adhesion (GO:0007159) | 2.40737832 |
| 131 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.40450893 |
| 132 | DNA duplex unwinding (GO:0032508) | 2.39392226 |
| 133 | ribosomal small subunit biogenesis (GO:0042274) | 2.39058077 |
| 134 | translational initiation (GO:0006413) | 2.37563070 |
| 135 | DNA deamination (GO:0045006) | 2.36683634 |
| 136 | DNA geometric change (GO:0032392) | 2.36538553 |
| 137 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35539020 |
| 138 | NADPH regeneration (GO:0006740) | 2.35330772 |
| 139 | regulation of erythrocyte differentiation (GO:0045646) | 2.34340397 |
| 140 | negative regulation of granulocyte differentiation (GO:0030853) | 2.34247662 |
| 141 | leukocyte mediated cytotoxicity (GO:0001909) | 2.34087455 |
| 142 | mast cell activation (GO:0045576) | 2.33903648 |
| 143 | DNA replication checkpoint (GO:0000076) | 2.33260940 |
| 144 | telomere maintenance via telomere lengthening (GO:0010833) | 2.32244195 |
| 145 | protein targeting to ER (GO:0045047) | 2.32115064 |
| 146 | NIK/NF-kappaB signaling (GO:0038061) | 2.32083311 |
| 147 | cotranslational protein targeting to membrane (GO:0006613) | 2.31403450 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.31318116 |
| 149 | viral life cycle (GO:0019058) | 2.30271650 |
| 150 | angiogenesis involved in wound healing (GO:0060055) | 2.28930467 |
| 151 | T cell homeostasis (GO:0043029) | 2.28644230 |
| 152 | interferon-gamma production (GO:0032609) | 2.27948790 |
| 153 | response to interferon-beta (GO:0035456) | 2.25399862 |
| 154 | positive regulation of lamellipodium organization (GO:1902745) | 2.25122061 |
| 155 | regulation of response to interferon-gamma (GO:0060330) | 2.24877325 |
| 156 | positive regulation of interferon-alpha production (GO:0032727) | 2.23964954 |
| 157 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.23877095 |
| 158 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.23877095 |
| 159 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.22353397 |
| 160 | nuclear pore complex assembly (GO:0051292) | 2.22139108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.00357087 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.04937356 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.93535864 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85482901 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77753052 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.66033327 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58143260 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.47953498 |
| 9 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.47606444 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.42737765 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.37579364 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.33713944 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.29433007 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26959095 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20545571 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17789053 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.17377594 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.15978212 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.01836911 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98064600 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.94909620 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93989869 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91984632 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90335381 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84906962 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81409340 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78326808 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.77712847 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77526303 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.76228710 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75899638 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75724699 |
| 33 | * MAF_26560356_Chip-Seq_TH1_Human | 1.75637598 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75547753 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73287672 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71582332 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69792527 |
| 38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.69657565 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68402835 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66589342 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62807300 |
| 42 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60887999 |
| 43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.60180597 |
| 44 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.59344001 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59189079 |
| 46 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.57313781 |
| 47 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.56012778 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.55692202 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52362210 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47830335 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46948904 |
| 52 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46179438 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41286010 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40780471 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.40406326 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38295989 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37459883 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36716573 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35414110 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34480386 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33744452 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33288982 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33094503 |
| 64 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.32847836 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31843638 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31143102 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29742118 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29499989 |
| 69 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29211163 |
| 70 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.29022652 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28980159 |
| 72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.27225083 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26712121 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24459755 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23139294 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21969442 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21035859 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20708366 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19362279 |
| 80 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.18948440 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18865203 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18017467 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17664738 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17482135 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17189914 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16820915 |
| 87 | * MAF_26560356_Chip-Seq_TH2_Human | 1.16694627 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15977437 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15976732 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15799375 |
| 91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15555672 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15534434 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15282796 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13814632 |
| 95 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13752985 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13533868 |
| 97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12639052 |
| 98 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12016030 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11548048 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11495693 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11112508 |
| 102 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10649398 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07384582 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07101530 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06725862 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06606284 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05146952 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04410032 |
| 109 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04181773 |
| 110 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03087428 |
| 111 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02096170 |
| 112 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01287844 |
| 113 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00456574 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00327337 |
| 115 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00104701 |
| 116 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.99795842 |
| 117 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99137658 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98328810 |
| 119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97781632 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97322316 |
| 121 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.96159971 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96093289 |
| 123 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95929798 |
| 124 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.95509688 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94553124 |
| 126 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.94152447 |
| 127 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93845274 |
| 128 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92122747 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92067717 |
| 130 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.91454597 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91373580 |
| 132 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90715744 |
| 133 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90560576 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90338748 |
| 135 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88990703 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 0.88288775 |
| 137 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87624174 |
| 138 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87415171 |
| 139 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86724676 |
| 140 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85460065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.35268248 |
| 2 | MP0002396_abnormal_hematopoietic_system | 2.95570295 |
| 3 | MP0003693_abnormal_embryo_hatching | 2.76009014 |
| 4 | MP0003436_decreased_susceptibility_to | 2.55011769 |
| 5 | MP0005671_abnormal_response_to | 2.52242810 |
| 6 | MP0000685_abnormal_immune_system | 2.41428947 |
| 7 | MP0009785_altered_susceptibility_to | 2.41189943 |
| 8 | MP0005025_abnormal_response_to | 2.29988838 |
| 9 | MP0001800_abnormal_humoral_immune | 2.29833924 |
| 10 | MP0003303_peritoneal_inflammation | 2.29235530 |
| 11 | MP0005451_abnormal_body_composition | 2.22752499 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.22609126 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.18210364 |
| 14 | MP0000490_abnormal_crypts_of | 2.15602992 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.14332169 |
| 16 | MP0001819_abnormal_immune_cell | 2.14282727 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.14258271 |
| 18 | MP0002398_abnormal_bone_marrow | 2.13549007 |
| 19 | MP0002419_abnormal_innate_immunity | 2.11461160 |
| 20 | MP0010094_abnormal_chromosome_stability | 2.10001397 |
| 21 | MP0004957_abnormal_blastocyst_morpholog | 2.07870761 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.04789868 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.03418158 |
| 24 | MP0002723_abnormal_immune_serum | 2.03365256 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.02439467 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 2.02360210 |
| 27 | MP0003111_abnormal_nucleus_morphology | 2.00946501 |
| 28 | MP0001873_stomach_inflammation | 1.97487640 |
| 29 | MP0003077_abnormal_cell_cycle | 1.96710332 |
| 30 | MP0008260_abnormal_autophagy | 1.96053060 |
| 31 | MP0008057_abnormal_DNA_replication | 1.91150167 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.89852512 |
| 33 | MP0000716_abnormal_immune_system | 1.86985090 |
| 34 | MP0002722_abnormal_immune_system | 1.86063930 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.85831664 |
| 36 | MP0001790_abnormal_immune_system | 1.84899791 |
| 37 | MP0005387_immune_system_phenotype | 1.84899791 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.84628933 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.83859348 |
| 40 | MP0002405_respiratory_system_inflammati | 1.82881073 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.80372078 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.80372078 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.79249778 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.76432852 |
| 45 | MP0009278_abnormal_bone_marrow | 1.75799159 |
| 46 | MP0003866_abnormal_defecation | 1.75493583 |
| 47 | MP0002429_abnormal_blood_cell | 1.71953107 |
| 48 | MP0006054_spinal_hemorrhage | 1.68359940 |
| 49 | MP0006082_CNS_inflammation | 1.62132145 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.54805293 |
| 51 | MP0010307_abnormal_tumor_latency | 1.54701837 |
| 52 | MP0001853_heart_inflammation | 1.54544102 |
| 53 | MP0002006_tumorigenesis | 1.53445362 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.51708991 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.49407868 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.47374239 |
| 57 | MP0004947_skin_inflammation | 1.42791335 |
| 58 | MP0000858_altered_metastatic_potential | 1.41142160 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.37912043 |
| 60 | MP0008058_abnormal_DNA_repair | 1.36729917 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.36029906 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.32611857 |
| 63 | MP0003075_altered_response_to | 1.29164739 |
| 64 | MP0008007_abnormal_cellular_replicative | 1.28808422 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.28750594 |
| 66 | MP0004510_myositis | 1.26618324 |
| 67 | MP0009764_decreased_sensitivity_to | 1.25684625 |
| 68 | MP0009840_abnormal_foam_cell | 1.24205477 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.22906317 |
| 70 | MP0000604_amyloidosis | 1.19213329 |
| 71 | MP0003724_increased_susceptibility_to | 1.18822173 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.18736847 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.18663108 |
| 74 | MP0005166_decreased_susceptibility_to | 1.14714893 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.12073703 |
| 76 | MP0000350_abnormal_cell_proliferation | 1.11851076 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.11499767 |
| 78 | MP0008469_abnormal_protein_level | 1.10774932 |
| 79 | MP0004381_abnormal_hair_follicle | 1.09534839 |
| 80 | MP0000313_abnormal_cell_death | 1.05679266 |
| 81 | MP0003448_altered_tumor_morphology | 1.05162994 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.04437715 |
| 83 | MP0001730_embryonic_growth_arrest | 1.04104693 |
| 84 | MP0005023_abnormal_wound_healing | 1.03440970 |
| 85 | MP0000477_abnormal_intestine_morphology | 0.99458855 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.98296659 |
| 87 | MP0000343_altered_response_to | 0.96781180 |
| 88 | MP0004883_abnormal_blood_vessel | 0.96402683 |
| 89 | MP0008004_abnormal_stomach_pH | 0.93516715 |
| 90 | MP0001851_eye_inflammation | 0.93152907 |
| 91 | MP0005310_abnormal_salivary_gland | 0.93081285 |
| 92 | MP0003690_abnormal_glial_cell | 0.90868255 |
| 93 | MP0001663_abnormal_digestive_system | 0.90484019 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.89549762 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 0.88151286 |
| 96 | MP0002086_abnormal_extraembryonic_tissu | 0.86897580 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.86890463 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.85368979 |
| 99 | MP0001915_intracranial_hemorrhage | 0.79591508 |
| 100 | MP0005164_abnormal_response_to | 0.77517326 |
| 101 | MP0005380_embryogenesis_phenotype | 0.76430114 |
| 102 | MP0001672_abnormal_embryogenesis/_devel | 0.76430114 |
| 103 | MP0002080_prenatal_lethality | 0.75894475 |
| 104 | MP0003984_embryonic_growth_retardation | 0.75221204 |
| 105 | MP0001697_abnormal_embryo_size | 0.74857692 |
| 106 | MP0008873_increased_physiological_sensi | 0.74730699 |
| 107 | MP0001849_ear_inflammation | 0.74130415 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 0.72554223 |
| 109 | MP0003091_abnormal_cell_migration | 0.69120743 |
| 110 | MP0005390_skeleton_phenotype | 0.68713904 |
| 111 | MP0002933_joint_inflammation | 0.67973656 |
| 112 | MP0002132_abnormal_respiratory_system | 0.67886775 |
| 113 | MP0003795_abnormal_bone_structure | 0.67321886 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.66624126 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 0.65749485 |
| 116 | MP0008932_abnormal_embryonic_tissue | 0.64651238 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.63735416 |
| 118 | MP0002139_abnormal_hepatobiliary_system | 0.63340961 |
| 119 | MP0003828_pulmonary_edema | 0.63292441 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.63291821 |
| 121 | MP0000609_abnormal_liver_physiology | 0.63211127 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.62928435 |
| 123 | MP0009763_increased_sensitivity_to | 0.62590980 |
| 124 | MP0000371_diluted_coat_color | 0.62232944 |
| 125 | MP0000598_abnormal_liver_morphology | 0.61589657 |
| 126 | MP0003329_amyloid_beta_deposits | 0.61291736 |
| 127 | MP0000249_abnormal_blood_vessel | 0.60121077 |
| 128 | MP0008874_decreased_physiological_sensi | 0.58448224 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.57352048 |
| 130 | MP0003045_fibrosis | 0.55174810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.75048746 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.24463049 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.88432597 |
| 4 | Thrombocytosis (HP:0001894) | 4.24029786 |
| 5 | Agnosia (HP:0010524) | 4.04169254 |
| 6 | IgM deficiency (HP:0002850) | 3.99481292 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86252166 |
| 8 | Myositis (HP:0100614) | 3.64813062 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.58966914 |
| 10 | Recurrent viral infections (HP:0004429) | 3.48267868 |
| 11 | Pustule (HP:0200039) | 3.36387678 |
| 12 | Petechiae (HP:0000967) | 3.35483167 |
| 13 | Chronic otitis media (HP:0000389) | 3.32203559 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.29569742 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.29569742 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.29569742 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.27863389 |
| 18 | Recurrent skin infections (HP:0001581) | 3.26200431 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22582495 |
| 20 | Obstructive lung disease (HP:0006536) | 3.22582495 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.19110516 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.17448145 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.06702621 |
| 24 | Abnormality of T cell physiology (HP:0011840) | 3.05104067 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 2.94752134 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.91120083 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.88966946 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 2.88723822 |
| 29 | Abnormal number of erythroid precursors (HP:0012131) | 2.85036323 |
| 30 | Cellulitis (HP:0100658) | 2.81886701 |
| 31 | Meningitis (HP:0001287) | 2.78505486 |
| 32 | Nasal polyposis (HP:0100582) | 2.77993389 |
| 33 | Abnormality of T cells (HP:0002843) | 2.74888997 |
| 34 | Agammaglobulinemia (HP:0004432) | 2.74809610 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73599274 |
| 36 | Reticulocytopenia (HP:0001896) | 2.73478044 |
| 37 | Pulmonary infiltrates (HP:0002113) | 2.64975980 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.62334657 |
| 39 | Loss of speech (HP:0002371) | 2.61651783 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.61275906 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.60793067 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.60470103 |
| 43 | Gingivitis (HP:0000230) | 2.58550717 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.55106503 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.53114121 |
| 46 | Periodontitis (HP:0000704) | 2.52553915 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.47056099 |
| 48 | Purpura (HP:0000979) | 2.45620079 |
| 49 | Colitis (HP:0002583) | 2.40660122 |
| 50 | Amaurosis fugax (HP:0100576) | 2.39569254 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.39365839 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.39365839 |
| 53 | Increased IgM level (HP:0003496) | 2.38927181 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.38150884 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.37226271 |
| 56 | Abnormality of the prostate (HP:0008775) | 2.37052991 |
| 57 | Orchitis (HP:0100796) | 2.36608830 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.34256092 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.33874770 |
| 60 | Abnormal platelet function (HP:0011869) | 2.33854479 |
| 61 | Impaired platelet aggregation (HP:0003540) | 2.33854479 |
| 62 | Amyloidosis (HP:0011034) | 2.33798875 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.33202796 |
| 64 | Abnormal platelet volume (HP:0011876) | 2.31523877 |
| 65 | Granulocytopenia (HP:0001913) | 2.29646833 |
| 66 | Leukocytosis (HP:0001974) | 2.28471353 |
| 67 | Aplastic anemia (HP:0001915) | 2.26964786 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.26855646 |
| 69 | Sepsis (HP:0100806) | 2.26850498 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.26562758 |
| 71 | Basal cell carcinoma (HP:0002671) | 2.26206501 |
| 72 | Eosinophilia (HP:0001880) | 2.26051119 |
| 73 | B lymphocytopenia (HP:0010976) | 2.23306321 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.23306321 |
| 75 | Stomatitis (HP:0010280) | 2.21596290 |
| 76 | Pulmonary embolism (HP:0002204) | 2.21278569 |
| 77 | Epistaxis (HP:0000421) | 2.21146963 |
| 78 | Increased serum ferritin (HP:0003281) | 2.21061379 |
| 79 | Increased IgE level (HP:0003212) | 2.20958078 |
| 80 | Chest pain (HP:0100749) | 2.20169107 |
| 81 | Spinal cord lesions (HP:0100561) | 2.19947972 |
| 82 | Syringomyelia (HP:0003396) | 2.19947972 |
| 83 | Premature loss of primary teeth (HP:0006323) | 2.19112595 |
| 84 | Malnutrition (HP:0004395) | 2.18200862 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.18186313 |
| 86 | Myelodysplasia (HP:0002863) | 2.17770313 |
| 87 | T lymphocytopenia (HP:0005403) | 2.16666924 |
| 88 | Hypochromic anemia (HP:0001931) | 2.15920678 |
| 89 | Lymphopenia (HP:0001888) | 2.15897672 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15876644 |
| 91 | Disinhibition (HP:0000734) | 2.14873311 |
| 92 | Skin ulcer (HP:0200042) | 2.14535181 |
| 93 | Lymphoma (HP:0002665) | 2.14356493 |
| 94 | Anorexia (HP:0002039) | 2.12184927 |
| 95 | Episodic fever (HP:0001954) | 2.11219647 |
| 96 | Vasculitis (HP:0002633) | 2.11002680 |
| 97 | Viral hepatitis (HP:0006562) | 2.08050487 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 2.04859732 |
| 99 | Urticaria (HP:0001025) | 2.03983901 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03438878 |
| 101 | Abnormality of T cell number (HP:0011839) | 2.02139102 |
| 102 | Restrictive lung disease (HP:0002091) | 2.01463025 |
| 103 | Poikiloderma (HP:0001029) | 2.01395634 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 1.98813666 |
| 105 | Abnormality of the fingertips (HP:0001211) | 1.97753627 |
| 106 | Abnormality of eosinophils (HP:0001879) | 1.97539938 |
| 107 | Recurrent pneumonia (HP:0006532) | 1.96890560 |
| 108 | Recurrent sinusitis (HP:0011108) | 1.96059568 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 1.95800122 |
| 110 | Retrobulbar optic neuritis (HP:0100654) | 1.94837879 |
| 111 | Optic neuritis (HP:0100653) | 1.94837879 |
| 112 | Combined immunodeficiency (HP:0005387) | 1.94591435 |
| 113 | Chronic diarrhea (HP:0002028) | 1.93747001 |
| 114 | Skin rash (HP:0000988) | 1.92475026 |
| 115 | Gangrene (HP:0100758) | 1.92349172 |
| 116 | Encephalitis (HP:0002383) | 1.91657677 |
| 117 | Ependymoma (HP:0002888) | 1.91576704 |
| 118 | Abnormality of the pleura (HP:0002103) | 1.90374801 |
| 119 | Hemoptysis (HP:0002105) | 1.90090734 |
| 120 | Increased mean platelet volume (HP:0011877) | 1.88978224 |
| 121 | Glomerulopathy (HP:0100820) | 1.87814642 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87593362 |
| 123 | Cheilitis (HP:0100825) | 1.87504851 |
| 124 | IgA deficiency (HP:0002720) | 1.87111126 |
| 125 | Gingival bleeding (HP:0000225) | 1.85721590 |
| 126 | Spondylolisthesis (HP:0003302) | 1.85441707 |
| 127 | Prostate neoplasm (HP:0100787) | 1.85222477 |
| 128 | Osteomyelitis (HP:0002754) | 1.84559398 |
| 129 | Arterial thrombosis (HP:0004420) | 1.83486140 |
| 130 | Leukopenia (HP:0001882) | 1.83467281 |
| 131 | Acute myeloid leukemia (HP:0004808) | 1.81048713 |
| 132 | Bone marrow hypocellularity (HP:0005528) | 1.77520146 |
| 133 | Degeneration of anterior horn cells (HP:0002398) | 1.77427302 |
| 134 | Abnormality of the anterior horn cell (HP:0006802) | 1.77427302 |
| 135 | Chromsome breakage (HP:0040012) | 1.76758291 |
| 136 | IgG deficiency (HP:0004315) | 1.76379597 |
| 137 | Hypergammaglobulinemia (HP:0010702) | 1.72553404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.10785341 |
| 2 | PRPF4B | 2.98459976 |
| 3 | EEF2K | 2.78834544 |
| 4 | STK10 | 2.50398322 |
| 5 | JAK3 | 2.44525280 |
| 6 | IRAK4 | 2.20935066 |
| 7 | BLK | 2.20297032 |
| 8 | BTK | 2.12171527 |
| 9 | TYK2 | 2.04545998 |
| 10 | ZAP70 | 2.03546133 |
| 11 | CSF1R | 2.01094225 |
| 12 | MAP3K13 | 1.99641304 |
| 13 | PKN2 | 1.99267674 |
| 14 | GRK6 | 1.98337117 |
| 15 | SMG1 | 1.95190339 |
| 16 | MAP2K3 | 1.87878394 |
| 17 | FLT3 | 1.87447404 |
| 18 | WEE1 | 1.78737308 |
| 19 | BUB1 | 1.72453987 |
| 20 | TXK | 1.71847991 |
| 21 | KIT | 1.64120756 |
| 22 | CDC7 | 1.64001397 |
| 23 | NME2 | 1.62448517 |
| 24 | TGFBR2 | 1.61227557 |
| 25 | NEK2 | 1.60346708 |
| 26 | FGR | 1.60291343 |
| 27 | TNK2 | 1.59691818 |
| 28 | PAK4 | 1.57319296 |
| 29 | ERN1 | 1.52975027 |
| 30 | RPS6KB2 | 1.49626597 |
| 31 | PIM1 | 1.46415784 |
| 32 | CDK12 | 1.46112833 |
| 33 | TESK2 | 1.42604230 |
| 34 | TBK1 | 1.40816726 |
| 35 | CLK1 | 1.40002763 |
| 36 | TEC | 1.37849588 |
| 37 | MAP3K1 | 1.29125225 |
| 38 | SYK | 1.28227595 |
| 39 | CSK | 1.27850950 |
| 40 | LRRK2 | 1.27180319 |
| 41 | MAP3K10 | 1.26934228 |
| 42 | CDK4 | 1.23822472 |
| 43 | EPHB1 | 1.20866865 |
| 44 | TSSK6 | 1.20093216 |
| 45 | TAOK2 | 1.20026096 |
| 46 | KSR2 | 1.17693652 |
| 47 | CDK7 | 1.14616720 |
| 48 | MST4 | 1.14319402 |
| 49 | IKBKB | 1.13915311 |
| 50 | RPS6KA4 | 1.13498198 |
| 51 | IRAK3 | 1.13285385 |
| 52 | TAOK3 | 1.12863605 |
| 53 | ITK | 1.12457828 |
| 54 | IKBKE | 1.10902753 |
| 55 | LCK | 1.10641068 |
| 56 | SCYL2 | 1.09407956 |
| 57 | SIK3 | 1.06737473 |
| 58 | STK4 | 1.03289187 |
| 59 | HCK | 1.03287820 |
| 60 | MATK | 1.02256941 |
| 61 | TRIB3 | 1.01745973 |
| 62 | BRSK2 | 0.99559514 |
| 63 | TGFBR1 | 0.98498927 |
| 64 | KDR | 0.98145773 |
| 65 | MAP3K14 | 0.95199363 |
| 66 | * MAP3K8 | 0.94480101 |
| 67 | FES | 0.92897136 |
| 68 | ATR | 0.91863679 |
| 69 | MAP3K11 | 0.90590984 |
| 70 | VRK1 | 0.86028881 |
| 71 | BMPR2 | 0.85853070 |
| 72 | YES1 | 0.85298863 |
| 73 | PASK | 0.84069081 |
| 74 | LYN | 0.83545538 |
| 75 | EIF2AK1 | 0.82705142 |
| 76 | JAK1 | 0.81546107 |
| 77 | CDK6 | 0.81007274 |
| 78 | EPHA2 | 0.80486499 |
| 79 | TTK | 0.79480118 |
| 80 | MARK2 | 0.78679649 |
| 81 | ALK | 0.78339226 |
| 82 | JAK2 | 0.76756810 |
| 83 | PTK6 | 0.75670932 |
| 84 | CDC42BPA | 0.73931985 |
| 85 | PIM2 | 0.73624844 |
| 86 | AURKB | 0.73400468 |
| 87 | IRAK2 | 0.73005629 |
| 88 | PRKG2 | 0.71287574 |
| 89 | TESK1 | 0.67384937 |
| 90 | SIK1 | 0.67061213 |
| 91 | IRAK1 | 0.66731746 |
| 92 | * PDK1 | 0.66636929 |
| 93 | MAPK12 | 0.66567836 |
| 94 | MAPKAPK3 | 0.65187860 |
| 95 | RIPK4 | 0.64726303 |
| 96 | MAP3K6 | 0.63770511 |
| 97 | PRKD2 | 0.63256715 |
| 98 | ACVR1B | 0.59773725 |
| 99 | PRKCQ | 0.59497115 |
| 100 | FGFR4 | 0.59189803 |
| 101 | * PDPK1 | 0.58343011 |
| 102 | FYN | 0.57954729 |
| 103 | CHUK | 0.57773957 |
| 104 | TRPM7 | 0.57741550 |
| 105 | MAP3K2 | 0.56796087 |
| 106 | FGFR3 | 0.55943279 |
| 107 | MAP2K6 | 0.55766741 |
| 108 | EIF2AK3 | 0.55667245 |
| 109 | MAPKAPK2 | 0.55631747 |
| 110 | SIK2 | 0.55343936 |
| 111 | PLK1 | 0.54941002 |
| 112 | MAPK11 | 0.54765695 |
| 113 | HIPK2 | 0.53616565 |
| 114 | NEK9 | 0.52575937 |
| 115 | STK16 | 0.52395091 |
| 116 | MARK3 | 0.51948799 |
| 117 | CDK19 | 0.51943318 |
| 118 | MAP3K3 | 0.50695921 |
| 119 | ICK | 0.49222414 |
| 120 | RIPK1 | 0.48865422 |
| 121 | GRK7 | 0.46865522 |
| 122 | TAOK1 | 0.46302696 |
| 123 | MAPK7 | 0.46096332 |
| 124 | MAP3K5 | 0.46040165 |
| 125 | RAF1 | 0.42435841 |
| 126 | RET | 0.41925915 |
| 127 | CAMKK1 | 0.40495017 |
| 128 | CAMKK2 | 0.39720377 |
| 129 | MAP2K2 | 0.39608051 |
| 130 | MAP3K7 | 0.37078373 |
| 131 | CHEK1 | 0.36392513 |
| 132 | CHEK2 | 0.36246550 |
| 133 | PIK3CG | 0.36052037 |
| 134 | TLK1 | 0.33922599 |
| 135 | PAK1 | 0.33593682 |
| 136 | DYRK3 | 0.33582464 |
| 137 | ARAF | 0.33057191 |
| 138 | MAP3K12 | 0.32981283 |
| 139 | PLK4 | 0.32226136 |
| 140 | PRKCD | 0.31949546 |
| 141 | DYRK1B | 0.29016195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.76349159 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 2.87771520 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.54600690 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.30054057 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28012319 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.21112908 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20298993 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.16759873 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.05662953 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98340237 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.91282201 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.83211784 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 1.75706423 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.66001918 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65977120 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61000569 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59687019 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.59132749 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55363702 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54573443 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54243571 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.50319081 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47721326 |
| 24 | RNA transport_Homo sapiens_hsa03013 | 1.45393471 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.43940886 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43716550 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42124221 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.39390146 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36799379 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36013959 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34622443 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33762674 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.33634586 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33210134 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.31690359 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30423187 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29456963 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25804375 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21813355 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.20603241 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.19128167 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.18462070 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17302814 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15839646 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.15365870 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14402080 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12957258 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12165761 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12015020 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 1.11282114 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09113940 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07616001 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06540388 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.06178107 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06176783 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03657483 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01551690 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 1.01415008 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.00587866 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99393913 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98943427 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97253370 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97059708 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95384108 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93256472 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.91635910 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.91517846 |
| 68 | Proteasome_Homo sapiens_hsa03050 | 0.91022324 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.89343075 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87735676 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.86183173 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83528612 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82974764 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82936724 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82528968 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80976471 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78311049 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78264509 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77055791 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75721691 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75273208 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74201873 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74162065 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.71732708 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.71483157 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71130655 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.68825147 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.67659318 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67512582 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67451525 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.66932573 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66115799 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65779157 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65771659 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.64731001 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64368644 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62271883 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58332843 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57847266 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.55627401 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55363134 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.55248597 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52822105 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51620354 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49807742 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49145151 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.48758937 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48736376 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48091299 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45488046 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44272223 |
| 112 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43786399 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43362222 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41723060 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40866709 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40598651 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38775819 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38699831 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38157877 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37762375 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.37468617 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36518030 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36450904 |
| 124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35338928 |
| 125 | * Insulin resistance_Homo sapiens_hsa04931 | 0.35014833 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34115100 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33080017 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29569885 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28004876 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27356278 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27188385 |

